Home Cart 0 Sign in  
X

[ CAS No. 535-11-5 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 535-11-5
Chemical Structure| 535-11-5
Chemical Structure| 535-11-5
Structure of 535-11-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Quality Control of [ 535-11-5 ]

Related Doc. of [ 535-11-5 ]

Alternatived Products of [ 535-11-5 ]

Product Details of [ 535-11-5 ]

CAS No. :535-11-5 MDL No. :MFCD00000144
Formula : C5H9BrO2 Boiling Point : -
Linear Structure Formula :- InChI Key :ARFLASKVLJTEJD-UHFFFAOYSA-N
M.W :181.03 Pubchem ID :79040
Synonyms :

Calculated chemistry of [ 535-11-5 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.8
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 35.3
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.22 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.05
Log Po/w (XLOGP3) : 1.67
Log Po/w (WLOGP) : 1.33
Log Po/w (MLOGP) : 1.45
Log Po/w (SILICOS-IT) : 1.17
Consensus Log Po/w : 1.54

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.82
Solubility : 2.76 mg/ml ; 0.0153 mol/l
Class : Very soluble
Log S (Ali) : -1.84
Solubility : 2.64 mg/ml ; 0.0146 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.65
Solubility : 4.07 mg/ml ; 0.0225 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.11

Safety of [ 535-11-5 ]

Signal Word:Danger Class:8,3
Precautionary Statements:P501-P240-P210-P233-P243-P241-P242-P264-P280-P370+P378-P303+P361+P353-P301+P330+P331-P363-P304+P340+P310-P305+P351+P338+P310-P403+P235-P405 UN#:2920
Hazard Statements:H314-H225 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 535-11-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 535-11-5 ]
  • Downstream synthetic route of [ 535-11-5 ]

[ 535-11-5 ] Synthesis Path-Upstream   1~25

  • 1
  • [ 95-55-6 ]
  • [ 535-11-5 ]
  • [ 21744-83-2 ]
YieldReaction ConditionsOperation in experiment
77.03% With potassium carbonate In N,N-dimethyl-formamide at 20 - 90℃; for 13.5 h; Cooling with ice 125 mM potassium carbonate was added to 100 mL of dry DMF (N, N-dimethylformamide)Add to it50 mM 2-amino-5-nitrophenol was stirred at room temperature for 1 h until it was completely dissolved.Under ice-cooling, a 50 mM solution of ethyl 2-bromopropionate in DMF was slowly added dropwise.After half an hour, the reaction solution was slowly warmed to room temperature and reacted at 90 ° C for 12 hours.After the reaction solution was cooled, part of the solvent was distilled off under reduced pressure,Slowly add ice water 300-500mL stirring with a solid precipitation,Stirring for half an hour under an ice bath, filtering,The filter cake was dried under vacuum to obtain pure intermediate product,6.28g as brown powder, yield 77.03percent.This intermediate was used directly in the next reaction without further purification.
Reference: [1] Tetrahedron Letters, 2010, vol. 51, # 14, p. 1852 - 1855
[2] Chemistry - A European Journal, 2011, vol. 17, # 6, p. 1884 - 1893
[3] Tetrahedron, 2005, vol. 61, # 28, p. 6879 - 6885
[4] Patent: CN107459494, 2017, A, . Location in patent: Paragraph 0279; 0281-0283
  • 2
  • [ 95-55-6 ]
  • [ 535-11-5 ]
  • [ 21744-83-2 ]
Reference: [1] Tetrahedron, 2005, vol. 61, # 28, p. 6879 - 6885
  • 3
  • [ 64-17-5 ]
  • [ 598-72-1 ]
  • [ 535-11-5 ]
YieldReaction ConditionsOperation in experiment
75% With hydrogenchloride In diethyl ether (a)(ii) 2-Bromopropionic acid ethyl ester 1 M HCI in Et2O (5 mL) was added to a solution of 2-bromopropionic acid (25 g) in EtOH (200 mL). The mixture was refluxed over night and the solvents were then evaporated to give a yellow oil, 20.4 g (approximately 75percent yield).1 H NMR (500 MHz, CHLOROFORM-cQ δ ppm 4.36 (q, J=7.00 Hz, 1 H) 4.24 (qd, J=IAQ, 2.69 Hz, 2 H) 1.83 (d, J=7.08 Hz, 3 H) 1.31 (t, J=7.20 Hz, 3 H).
Reference: [1] ACS Medicinal Chemistry Letters, 2017, vol. 8, # 3, p. 304 - 309
[2] Patent: WO2010/86613, 2010, A1, . Location in patent: Page/Page column 39
[3] Journal of the American Chemical Society, 2014, vol. 136, # 50, p. 17662 - 17668
[4] Justus Liebigs Annalen der Chemie, 1879, vol. 197, p. 13
[5] Monatshefte fuer Chemie, 1881, vol. 2, p. 546
[6] Justus Liebigs Annalen der Chemie, 1881, vol. 206, p. 319[7] Justus Liebigs Annalen der Chemie, 1882, vol. 214, p. 55
[8] Bulletin de la Societe Chimique de France, 1892, vol. <3>7, p. 359[9] Bulletin de la Societe Chimique de France, 1894, vol. 11, p. 297
[10] Justus Liebigs Annalen der Chemie, 1883, vol. 216, p. 32
[11] Justus Liebigs Annalen der Chemie, 1879, vol. 197, p. 13
[12] Monatshefte fuer Chemie, 1881, vol. 2, p. 546
[13] Justus Liebigs Annalen der Chemie, 1881, vol. 206, p. 319[14] Justus Liebigs Annalen der Chemie, 1882, vol. 214, p. 55
[15] Bulletin de la Societe Chimique de France, 1892, vol. <3>7, p. 359[16] Bulletin de la Societe Chimique de France, 1894, vol. 11, p. 297
[17] Justus Liebigs Annalen der Chemie, 1883, vol. 216, p. 32
[18] Patent: WO2004/58705, 2004, A2, . Location in patent: Page 58-59
  • 4
  • [ 64-17-5 ]
  • [ 563-76-8 ]
  • [ 535-11-5 ]
Reference: [1] Chemische Berichte, 1891, vol. 24, p. 2218
[2] Justus Liebigs Annalen der Chemie, 1894, vol. 280, p. 248
[3] Chemische Berichte, 1889, vol. 22, p. 62
[4] Journal of the Chemical Society, 1948, p. 642[5] Journal of the Chemical Society, 1934, p. 339
[6] Annales de Chimie (Cachan, France), 1935, vol. <11>3, p. 156,170,173[7] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1934, vol. 198, p. 2103
[8] Chemische Berichte, 1887, vol. 20, p. 2021
[9] Biochemical Pharmacology, 2005, vol. 69, # 9, p. 1351 - 1361
[10] Bioorganic and Medicinal Chemistry, 2007, vol. 15, # 8, p. 2827 - 2836
[11] Organic and Biomolecular Chemistry, 2006, vol. 4, # 15, p. 2874 - 2882
[12] Asian Journal of Chemistry, 2012, vol. 24, # 2, p. 929 - 930
[13] Organic Letters, 2016, vol. 18, # 10, p. 2443 - 2446
[14] Synthesis (Germany), 2018, vol. 50, # 16, p. 3187 - 3196
  • 5
  • [ 687-47-8 ]
  • [ 535-11-5 ]
Reference: [1] Journal of Organic Chemistry, 1997, vol. 62, # 20, p. 7061 - 7064
  • 6
  • [ 64-17-5 ]
  • [ 802294-64-0 ]
  • [ 535-11-5 ]
Reference: [1] Molecules, 2018, vol. 23, # 9,
  • 7
  • [ 21504-43-8 ]
  • [ 535-11-5 ]
Reference: [1] Journal of the American Chemical Society, 1955, vol. 77, p. 3786,3789
  • 8
  • [ 105-37-3 ]
  • [ 535-11-5 ]
Reference: [1] Journal of Organic Chemistry, 1953, vol. 18, p. 649,651
  • 9
  • [ 97-64-3 ]
  • [ 535-11-5 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1870, vol. 156, p. 176
  • 10
  • [ 64-17-5 ]
  • [ 5445-17-0 ]
  • [ 67-56-1 ]
  • [ 535-11-5 ]
Reference: [1] Tetrahedron Letters, 1990, vol. 31, # 34, p. 4883 - 4886
  • 11
  • [ 64-17-5 ]
  • [ 3156-70-5 ]
  • [ 535-11-5 ]
Reference: [1] Patent: DE868906, 1943, ,
  • 12
  • [ 64-17-5 ]
  • [ 7148-74-5 ]
  • [ 535-11-5 ]
Reference: [1] Journal of the Chemical Society, 1948, p. 642[2] Journal of the Chemical Society, 1934, p. 339
[3] Annales de Chimie (Cachan, France), 1935, vol. <11>3, p. 156,170,173[4] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1934, vol. 198, p. 2103
  • 13
  • [ 56-23-5 ]
  • [ 7726-95-6 ]
  • [ 21504-43-8 ]
  • [ 74-96-4 ]
  • [ 408325-87-1 ]
  • [ 535-11-5 ]
Reference: [1] Journal of the American Chemical Society, 1952, vol. 74, p. 1816,1818
  • 14
  • [ 74-89-5 ]
  • [ 535-11-5 ]
  • [ 600-21-5 ]
Reference: [1] Hoppe-Seyler's Zeitschrift fuer Physiologische Chemie, 1909, vol. 61, p. 46
  • 15
  • [ 535-11-5 ]
  • [ 4324-37-2 ]
Reference: [1] Patent: US4314842, 1982, A,
  • 16
  • [ 124-41-4 ]
  • [ 535-11-5 ]
  • [ 4324-37-2 ]
Reference: [1] Zhurnal Obshchei Khimii, 1953, vol. 23, p. 737,740,741;engl.Ausg.S.769,770,772
  • 17
  • [ 535-11-5 ]
  • [ 349-43-9 ]
Reference: [1] Journal of Fluorine Chemistry, 1999, vol. 99, # 2, p. 115 - 117
[2] ACS Medicinal Chemistry Letters, 2017, vol. 8, # 3, p. 304 - 309
[3] Bulletin de la Societe Chimique de France, 1964, p. 2254 - 2257
[4] Comptes Rendus des Seances de l'Academie des Sciences, Serie C: Sciences Chimiques, 1969, vol. 268, p. 2352 - 2354
[5] Comptes Rendus des Seances de l'Academie des Sciences, Serie C: Sciences Chimiques, 1969, vol. 268, p. 2352 - 2354
[6] Journal of the American Chemical Society, 1961, vol. 83, p. 1945 - 1950
  • 18
  • [ 535-11-5 ]
  • [ 3699-67-0 ]
Reference: [1] Patent: US5162566, 1992, A,
  • 19
  • [ 150-76-5 ]
  • [ 535-11-5 ]
  • [ 13794-15-5 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 2008, vol. 81, # 5, p. 617 - 622
  • 20
  • [ 121-44-8 ]
  • [ 535-11-5 ]
  • [ 82614-48-0 ]
  • [ 71-91-0 ]
  • [ 636-70-4 ]
Reference: [1] Danske Vid.Selsk.Mat.fys.Medd., 1943, vol. 20, # 13, p. 8,9[2] Chem.Abstr., 1945, p. 1844
  • 21
  • [ 121-44-8 ]
  • [ 108-88-3 ]
  • [ 535-11-5 ]
  • [ 82614-48-0 ]
  • [ 71-91-0 ]
  • [ 636-70-4 ]
Reference: [1] Danske Vid.Selsk.Mat.fys.Medd., 1943, vol. 20, # 13, p. 8,9[2] Chem.Abstr., 1945, p. 1844
  • 22
  • [ 535-11-5 ]
  • [ 617-27-6 ]
Reference: [1] Synthesis, 1985, # 2, p. 202 - 204
  • 23
  • [ 603-35-0 ]
  • [ 535-11-5 ]
  • [ 30018-16-7 ]
YieldReaction ConditionsOperation in experiment
80.5% at 20℃; for 24 h; The 1g of triphenylphosphine were dissolved in 15mL ethyl acetate was added 2-bromopropionate ethyl ester0.55mL2-, the reaction was stirred at room temperature 24h, and gradually a large amount of white solid was suction filtered, rinsed with ethyl acetate to give 1.35 g of a white solid, yield rate of 80.5percent.
144 g With potassium iodide In water; toluene at 20 - 75℃; for 15 h; At 20-30°C,To a solution of triphenylphosphine (88 g) in toluene (the organic phase recovered in the first step of Example 3), an aqueous solution of potassium iodide (3 g) was added (the mother liquor from the first step of Example 3).Then alpha-bromo-propionic acid ethyl ester (60 g) is added,Reaction at 70-75 ° C for 15h;After the reaction is complete,Phase,Water cooling,Crystallization,Filtered to give the ethoxycarbonyl ethyl triphenylphosphonium bromide (144g);Organic phase recovery application,Aqueous mother liquor recovery application.
Reference: [1] European Journal of Organic Chemistry, 2016, vol. 2016, # 12, p. 2110 - 2114
[2] Chemistry - A European Journal, 2015, vol. 21, # 20, p. 7408 - 7412
[3] Tetrahedron, 2010, vol. 66, # 26, p. 4745 - 4759
[4] Journal of Organic Chemistry, 1984, vol. 49, # 22, p. 4293 - 4295
[5] Patent: CN103864753, 2016, B, . Location in patent: Paragraph 0087; 0110-0111
[6] Angewandte Chemie - International Edition, 2018, vol. 57, # 24, p. 7240 - 7244[7] Angew. Chem., 2018, # 130, p. 7360 - 7364,5
[8] Tetrahedron, 1991, vol. 47, # 18-19, p. 2991 - 2998
[9] Journal of Fluorine Chemistry, 1985, vol. 29, p. 363 - 384
[10] Organic and Biomolecular Chemistry, 2004, vol. 2, # 10, p. 1456 - 1470
[11] Organic Letters, 2010, vol. 12, # 2, p. 240 - 243
[12] Advanced Synthesis and Catalysis, 2011, vol. 353, # 6, p. 913 - 917
[13] Chemistry - A European Journal, 2011, vol. 17, # 27, p. 7409 - 7413
[14] Chemistry - A European Journal, 2012, vol. 18, # 31, p. 9645 - 9650
[15] Organic Letters, 2016, vol. 18, # 10, p. 2443 - 2446
[16] Tetrahedron, 2016, vol. 72, # 37, p. 5707 - 5712
[17] Patent: JP5793025, 2015, B2, . Location in patent: Paragraph 0037
[18] Organic Letters, 2017, vol. 19, # 13, p. 3478 - 3481
[19] Patent: CN107759634, 2018, A, . Location in patent: Paragraph 0036; 0037; 0043; 0044
[20] Synthesis (Germany), 2018, vol. 50, # 16, p. 3187 - 3196
  • 24
  • [ 269410-08-4 ]
  • [ 535-11-5 ]
  • [ 1220968-24-0 ]
YieldReaction ConditionsOperation in experiment
61% With caesium carbonate In acetonitrile at 90℃; for 4 h; A mixture of 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (0.40 g, 2.1 mmol, Aldrich, Cat. 525057), ethyl 2-bromopropanoate (290 μL, 2.3 mmol), and cesium carbonate (1.5 g, 4.6 mmol) in acetonitrile (8 mL) was stirred at 90° C. for 4 h. After cooling, the reaction mixture was worked up with aqueous Na2CO3, extracted with ethyl acetate (3.x.20 mL), and washed with brine. The combined organic layers were dried over MgSO4, filtered and concentrated under reduced pressure. The residue was purified by flash chromatography on a silica gel column with ethyl acetate in hexanes (0-50percent) to afford the desired product (0.42 g, 61percent). LCMS (M+H)+: m/z=295.1.
21.6 g With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 14 h; Step 9
Ethyl 2-[4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)-1H-pyrazol-1-yl]propionate
To a suspension of 4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)-1H-pyrazole (21.3 g) and potassium carbonate (20.7 g) in dimethylformamide (100 ml) was added ethyl 2-bromopropionate (13 ml), and the mixture was stirred at 80° C. for 14 hr.
The reaction mixture was cooled to 0° C., and toluene (100 ml) and water (150 ml) were successively added dropwise.
The mixture was partitioned, and the aqueous layer was extracted with toluene (50 ml).
The combined organic layer was successively washed once with 10percent aqueous potassium carbonate solution (50 ml), twice with water (50 ml) and once with saturated brine (50 ml).
The obtained organic layer was dried over anhydrous sodium sulfate, and filtered.
The filtrate was concentrated under reduced pressure to give the title compound (21.6 g).
1H-NMR (400 MHz, CDCl3) δ: 7.85 (1H, s), 7.81 (1H, s), 5.10 (1H, q, J=7.3 Hz), 4.19 (2H, q, J=7.1 Hz), 1.78 (3H, d, J=7.4 Hz), 1.32 (12H, s), 1.25 (3H, t, J=7.2 Hz).
Reference: [1] Patent: US2012/165305, 2012, A1, . Location in patent: Page/Page column 43
[2] Patent: US2014/296316, 2014, A1, . Location in patent: Paragraph 0193; 0194; 0195
  • 25
  • [ 535-11-5 ]
  • [ 1220968-24-0 ]
Reference: [1] Patent: EP3042907, 2016, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 535-11-5 ]

Aliphatic Cyclic Hydrocarbons

Chemical Structure| 89544-83-2

[ 89544-83-2 ]

Ethyl 1-bromocyclopropanecarboxylate

Similarity: 0.74

Chemical Structure| 1200828-74-5

[ 1200828-74-5 ]

Ethyl 2-bromo-2-cyclopropylacetate

Similarity: 0.72

Chemical Structure| 96999-01-8

[ 96999-01-8 ]

Methyl 1-bromocyclopropanecarboxylate

Similarity: 0.71

Chemical Structure| 35120-18-4

[ 35120-18-4 ]

Ethyl 1-bromocyclobutanecarboxylate

Similarity: 0.68

Chemical Structure| 51175-79-2

[ 51175-79-2 ]

Methyl 1-bromocyclobutanecarboxylate

Similarity: 0.66

Bromides

Chemical Structure| 5445-17-0

[ 5445-17-0 ]

Methyl 2-bromopropanoate

Similarity: 0.96

Chemical Structure| 685-87-0

[ 685-87-0 ]

Diethyl 2-bromomalonate

Similarity: 0.90

Chemical Structure| 7691-28-3

[ 7691-28-3 ]

Methyl 2-bromo-3-hydroxypropanoate

Similarity: 0.90

Chemical Structure| 39149-80-9

[ 39149-80-9 ]

tert-Butyl 2-bromopropanoate

Similarity: 0.88

Chemical Structure| 3674-13-3

[ 3674-13-3 ]

Ethyl 2,3-Dibromopropionate

Similarity: 0.88

Esters

Chemical Structure| 5445-17-0

[ 5445-17-0 ]

Methyl 2-bromopropanoate

Similarity: 0.96

Chemical Structure| 685-87-0

[ 685-87-0 ]

Diethyl 2-bromomalonate

Similarity: 0.90

Chemical Structure| 7691-28-3

[ 7691-28-3 ]

Methyl 2-bromo-3-hydroxypropanoate

Similarity: 0.90

Chemical Structure| 39149-80-9

[ 39149-80-9 ]

tert-Butyl 2-bromopropanoate

Similarity: 0.88

Chemical Structure| 3674-13-3

[ 3674-13-3 ]

Ethyl 2,3-Dibromopropionate

Similarity: 0.88